Skip to content
Disclosery

EXANE DERIVATIVES: FXI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FXI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9 FXI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9 shares
    Change vs previous 13F -3 shares

    <0.01% of the 13F portfolio, value $305.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 12 shares
    Change vs previous 13F -36,449 shares

    <0.01% of the 13F portfolio, value $384.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 36,461 shares
    Change vs previous 13F +12,201 shares

    0.32% of the 13F portfolio, value $1,333,677.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 24,260 shares
    Change vs previous 13F +10,308 shares

    0.24% of the 13F portfolio, value $944,395.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 13,952 shares
    Change vs previous 13F +158 shares

    0.15% of the 13F portfolio, value $620,845.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 13,794 shares
    Change vs previous 13F +301 shares

    0.19% of the 13F portfolio, value $643,589.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 13,493 shares
    Change vs previous 13F -940 shares

    0.19% of the 13F portfolio, value $626,441.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 14,433 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $606,161.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).